Access & Pricing Strategy Leader - UK & Ireland

Galderma Limited (UK) in London seeks a strategic Head of Market Access & Pricing to lead the UK & Ireland access agenda for the Therapeutic Dermatology portfolio. You will bridge clinical evidence, payer relationships and commercial strategy to optimise reimbursement and patient access.

The role focuses on Nemolizumab, its formulary uptake, and relationships across NHS England, ICBs and hospital stakeholders, with cross functional collaboration for portfolio-wide access.